These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
486 related articles for article (PubMed ID: 19589011)
1. Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs. Esposito D; Bagchi AD; Verdier JM; Bencio DS; Kim MS Am J Manag Care; 2009 Jul; 15(7):437-45. PubMed ID: 19589011 [TBL] [Abstract][Full Text] [Related]
2. Utilization of, and adherence to, drug therapy among medicaid beneficiaries with congestive heart failure. Bagchi AD; Esposito D; Kim M; Verdier J; Bencio D Clin Ther; 2007 Aug; 29(8):1771-83. PubMed ID: 17919558 [TBL] [Abstract][Full Text] [Related]
3. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study. Faught RE; Weiner JR; Guérin A; Cunnington MC; Duh MS Epilepsia; 2009 Mar; 50(3):501-9. PubMed ID: 19183224 [TBL] [Abstract][Full Text] [Related]
4. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients. Cheong C; Barner JC; Lawson KA; Johnsrud MT Clin Ther; 2008 Oct; 30(10):1893-907. PubMed ID: 19014846 [TBL] [Abstract][Full Text] [Related]
5. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Karve S; Cleves MA; Helm M; Hudson TJ; West DS; Martin BC Curr Med Res Opin; 2009 Sep; 25(9):2303-10. PubMed ID: 19635045 [TBL] [Abstract][Full Text] [Related]
6. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen. Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734 [TBL] [Abstract][Full Text] [Related]
7. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction. Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916 [TBL] [Abstract][Full Text] [Related]
8. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis. Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the impact of medication therapy management delivered to home-based Medicare beneficiaries. Welch EK; Delate T; Chester EA; Stubbings T Ann Pharmacother; 2009 Apr; 43(4):603-10. PubMed ID: 19318600 [TBL] [Abstract][Full Text] [Related]
10. Duloxetine compliance and its association with healthcare costs among patients with diabetic peripheral neuropathic pain. Wu N; Chen S; Boulanger L; Fraser K; Bledsoe SL; Zhao Y J Med Econ; 2009 Sep; 12(3):192-202. PubMed ID: 19705975 [TBL] [Abstract][Full Text] [Related]
11. Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetes. Wu J; Seiber E; Lacombe VA; Nahata MC; Balkrishnan R Ann Pharmacother; 2011 Mar; 45(3):342-9. PubMed ID: 21325098 [TBL] [Abstract][Full Text] [Related]
12. Effects of reaching the drug benefit threshold on Medicare members' healthcare utilization during the first year of Medicare Part D. Raebel MA; Delate T; Ellis JL; Bayliss EA Med Care; 2008 Oct; 46(10):1116-22. PubMed ID: 18815534 [TBL] [Abstract][Full Text] [Related]
13. Drug copayment and adherence in chronic heart failure: effect on cost and outcomes. Cole JA; Norman H; Weatherby LB; Walker AM Pharmacotherapy; 2006 Aug; 26(8):1157-64. PubMed ID: 16863491 [TBL] [Abstract][Full Text] [Related]
14. Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population. Simoni-Wastila L; Wei YJ; Qian J; Zuckerman IH; Stuart B; Shaffer T; Dalal AA; Bryant-Comstock L Am J Geriatr Pharmacother; 2012 Jun; 10(3):201-10. PubMed ID: 22521808 [TBL] [Abstract][Full Text] [Related]
15. Analysis of costs, length of stay, and utilization of emergency department services by frequent users: implications for health policy. Ruger JP; Richter CJ; Spitznagel EL; Lewis LM Acad Emerg Med; 2004 Dec; 11(12):1311-7. PubMed ID: 15576522 [TBL] [Abstract][Full Text] [Related]
16. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Dragomir A; Côté R; Roy L; Blais L; Lalonde L; Bérard A; Perreault S Med Care; 2010 May; 48(5):418-25. PubMed ID: 20393367 [TBL] [Abstract][Full Text] [Related]
17. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128 [TBL] [Abstract][Full Text] [Related]
18. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Karve S; Cleves MA; Helm M; Hudson TJ; West DS; Martin BC Med Care; 2008 Nov; 46(11):1125-33. PubMed ID: 18953222 [TBL] [Abstract][Full Text] [Related]
19. Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population. Piecoro LT; Potoski M; Talbert JC; Doherty DE Health Serv Res; 2001 Jun; 36(2):357-71. PubMed ID: 11409817 [TBL] [Abstract][Full Text] [Related]
20. Is there a relationship between early statin compliance and a reduction in healthcare utilization? Aubert RE; Yao J; Xia F; Garavaglia SB Am J Manag Care; 2010 Jun; 16(6):459-66. PubMed ID: 20560689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]